CIBC Innovation Banking, a financial services provider, completed an investment in InsightRX, a software company leveraging quantitative pharmacology and artificial intelligence. Financial terms were not disclosed. “We’re excited to work with the InsightRX leadership team as they use artificial intelligence to blaze a trail in drug development in biopharma clinical trials and in helping healthcare providers ensure patients are receiving optimal drug dosing. InsightRX will play a significant role in enhancing the development of new therapies that will improve patient safety in the healthcare drug development and delivery chain,” John Flemming, CIBC Innovation Banking Managing Director of Seattle.